miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2

  • Authors:
    • Hongtao Wang
    • Domkam Kanmangne
    • Rui Li
    • Zhongqing Qian
    • Xiaoying Xia
    • Xiaojing Wang
    • Ting Wang
  • View Affiliations

  • Published online on: December 10, 2019     https://doi.org/10.3892/or.2019.7423
  • Pages: 646-654
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is a leading cause of cancer‑related morbidity and mortality worldwide. Although there are currently various therapeutic strategies including surgery, chemotherapy and radiotherapy, lung cancer still results in high mortality with a 5‑year survival rate of less than 20%. The increasing need for new therapeutic targets and diagnostic/prognostic tools for lung cancer has promoted the demand for a better molecular and mechanistic understanding of its pathobiology. microRNA‑30a‑3p (miR‑30a‑3p) was recently recognized to be closely involved in the regulation of cancer cell invasion, migration and proliferation. However, the mechanistic role of miR‑30a‑3p in regulating the biological behavior of lung cancer, especially lung adenocarcinoma (LADC), is unknown. In the present study, we aimed to confirm the downregulation of miR‑30a‑3p in LADC tissues, and validate its functional impact on the pathogenesis of LADC via its molecular target, canopy fibroblast growth factor signaling regulator 2 (CNPY2), a known oncogene. Our data confirmed that CNPY2 was upregulated in LADC tissues, and the expression level of CNPY2 was correlated with the clinical outcomes of lung cancer patients. miR‑30a‑3p was confirmed as a key negative regulator of CNPY2 and reduced miR‑30a‑3p expression resulted in CNPY2 upregulation in LADC tissues. We then validated the functional outcome of miR‑30a‑3p in cancer pathobiology by the overexpression of miR‑30a‑3p in the LADC EKVX cell line. miR‑30a‑3p overexpression inhibited cancer cell proliferation, invasion and migration, by suppressing CNPY2 expression. In addition, miR‑30a‑3p inhibited epithelial‑mesenchymal transition, a key feature of LADC, via CNPY2 suppression. Taken together, these findings suggest that miR‑30a‑3p exerts a novel inhibitory role in the pathogenesis of LADC via CNPY2 downregulation, and the miR‑30a‑3p/CNPY2 pathway is a potential therapeutic target for human LADC.
View Figures
View References

Related Articles

Journal Cover

February 2020
Volume 43 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Wang, H., Kanmangne, D., Li, R., Qian, Z., Xia, X., Wang, X., & Wang, T. (2020). miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2. Oncology Reports, 43, 646-654. https://doi.org/10.3892/or.2019.7423
MLA
Wang, H., Kanmangne, D., Li, R., Qian, Z., Xia, X., Wang, X., Wang, T."miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2". Oncology Reports 43.2 (2020): 646-654.
Chicago
Wang, H., Kanmangne, D., Li, R., Qian, Z., Xia, X., Wang, X., Wang, T."miR‑30a‑3p suppresses the proliferation and migration of lung adenocarcinoma cells by downregulating CNPY2". Oncology Reports 43, no. 2 (2020): 646-654. https://doi.org/10.3892/or.2019.7423